Barry H. Paw
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Barry H. Paw has a total of 580 co-authors. Here are the top co-authors by number of shared publications:
Leonard I. Zon
Howard Hughes Medical Institute and Stem Cell Program, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, 02115, USA
21 shared publicationsYi Zhou
Department of Medicine, Division of Hematology-Oncology, Boston Children’s Hospital, Harvard Medical School, Boston, 02115, Massachusetts, USA
11 shared publicationsJeffrey D. Cooney
10 shared publicationsJerry Kaplan
Department of Pathology, University of Utah School of Medicine, Salt Lake City, United States
10 shared publicationsNathaniel B. Langer
10 shared publicationsYvette Y. Yien
Division of Hematology, Brigham & Women's Hospital, Harvard Medical School, Boston, MA 02115
10 shared publications
Latest Publications
- 1 October 2020
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 130 (10) , 5245-5256
Mutations in the iron-sulfur cluster biogenesis protein HSCB cause congenital sideroblastic anemia
The congenital sideroblastic anemias (CSAs) can be caused by primary defects in mitochondrial iron-sulfur (Fe-S) cluster biogenesis. HSCB (heat shock cognate B), which encodes a mitochondrial cochaperone, also known as HSC20 (heat shock cognate protein 20), is the partner of mitochondrial heat shock protein A9 (HSPA9). Together with glutaredoxin 5 (GLRX5), HSCB and HSPA9 facilitate the transfer of nascent 2-iron, 2-sulfur clusters to recipient mitochondrial proteins. Mutations in both HSPA9 and GLRX5 have previously been associated with CSA. Therefore, we hypothesized that mutations in HSCB could also cause CSA. We screened patients with genetically undefined CSA and identified a frameshift mutation and a rare promoter variant in HSCB in a female patient with non-syndromic CSA. We found that HSCB expression was decreased in patient-derived fibroblasts and K562 erythroleukemia cells engineered to have the patient-specific promoter variant. Furthermore, gene knockdown and deletion experiments performed in K562 cells, zebrafish, and mice demonstrate that loss of HSCB results in impaired Fe-S cluster biogenesis, a defect in RBC hemoglobinization, and the development of siderocytes and more broadly perturbs hematopoiesis in vivo. These results further affirm the involvement of Fe-S cluster biogenesis in erythropoiesis and hematopoiesis and define HSCB as a CSA gene.
- 1 October 2020
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 130 (10) , 5245-5256
Mutations in the iron-sulfur cluster biogenesis protein HSCB cause congenital sideroblastic anemia
The congenital sideroblastic anemias (CSAs) can be caused by primary defects in mitochondrial iron-sulfur (Fe-S) cluster biogenesis. HSCB (heat shock cognate B), which encodes a mitochondrial cochaperone, also known as HSC20 (heat shock cognate protein 20), is the partner of mitochondrial heat shock protein A9 (HSPA9). Together with glutaredoxin 5 (GLRX5), HSCB and HSPA9 facilitate the transfer of nascent 2-iron, 2-sulfur clusters to recipient mitochondrial proteins. Mutations in both HSPA9 and GLRX5 have previously been associated with CSA. Therefore, we hypothesized that mutations in HSCB could also cause CSA. We screened patients with genetically undefined CSA and identified a frameshift mutation and a rare promoter variant in HSCB in a female patient with non-syndromic CSA. We found that HSCB expression was decreased in patient-derived fibroblasts and K562 erythroleukemia cells engineered to have the patient-specific promoter variant. Furthermore, gene knockdown and deletion experiments performed in K562 cells, zebrafish, and mice demonstrate that loss of HSCB results in impaired Fe-S cluster biogenesis, a defect in RBC hemoglobinization, and the development of siderocytes and more broadly perturbs hematopoiesis in vivo. These results further affirm the involvement of Fe-S cluster biogenesis in erythropoiesis and hematopoiesis and define HSCB as a CSA gene.
- 27 October 2017
- Published by Springer Nature
- Vol. 1698, 11-36
Using the Zebrafish as an Approach to Examine the Mechanisms of Vertebrate Erythropoiesis
The zebrafish, Danio rerio, is a powerful model for the study of erythropoiesis and defining the genetic basis of hematological diseases. The mechanisms of erythroid differentiation are highly conserved in the zebrafish, permitting translational research studies and the modeling of erythropoiesis in higher vertebrates. An advantage of the system is the ability to manipulate gene expression and observe the effect on erythroid development in vivo, with relative ease and rapidity. The production of optically transparent embryos also makes it an attractive tool for visual analysis of circulating erythrocytes that can be used to study erythropoiesis. Through large-scale chemical mutagenesis screens, a variety of zebrafish blood mutants have been identified that are used for gene discoveries and the recapitulation of human diseases. Experimental techniques including in situ hybridization, o-dianisidine staining, flow cytometry, and microinjection are now commonly employed to study red blood cell biochemistry and erythropoiesis in the zebrafish. These techniques have been applied for identifying novel genes required for the hemoglobin synthesis, isolating blood cell lineages, visualizing genetic expression within erythroid tissues, and characterizing the phenotype of blood disorders. The applications of zebrafish methodology to the study of erythropoiesis and optimized step-by-step protocols are discussed in this chapter.
- 27 October 2017
- Published by Springer Nature
- Vol. 1698, 11-36
Using the Zebrafish as an Approach to Examine the Mechanisms of Vertebrate Erythropoiesis
The zebrafish, Danio rerio, is a powerful model for the study of erythropoiesis and defining the genetic basis of hematological diseases. The mechanisms of erythroid differentiation are highly conserved in the zebrafish, permitting translational research studies and the modeling of erythropoiesis in higher vertebrates. An advantage of the system is the ability to manipulate gene expression and observe the effect on erythroid development in vivo, with relative ease and rapidity. The production of optically transparent embryos also makes it an attractive tool for visual analysis of circulating erythrocytes that can be used to study erythropoiesis. Through large-scale chemical mutagenesis screens, a variety of zebrafish blood mutants have been identified that are used for gene discoveries and the recapitulation of human diseases. Experimental techniques including in situ hybridization, o-dianisidine staining, flow cytometry, and microinjection are now commonly employed to study red blood cell biochemistry and erythropoiesis in the zebrafish. These techniques have been applied for identifying novel genes required for the hemoglobin synthesis, isolating blood cell lineages, visualizing genetic expression within erythroid tissues, and characterizing the phenotype of blood disorders. The applications of zebrafish methodology to the study of erythropoiesis and optimized step-by-step protocols are discussed in this chapter.
- Open Access
- 5 September 2017
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 114 (38) , E8045-E8052
Mutation in human CLPX elevates levels of δ- aminolevulinate synthase and protoporphyrin IX to promote erythropoietic protoporphyria
Significance: Although heme synthesis is ubiquitous, specific regulatory mechanisms couple heme production to cellular demand and environmental conditions. The importance of these regulatory mechanisms is highlighted by clinical variability in porphyrias caused by loss-of-function mutations in heme synthesis enzymes. Heme synthesis is also controlled by the mitochondrial AAA+ unfoldase ClpX, which participates in both heme-dependent degradation of δ-aminolevulinate synthase (ALAS) and ALAS activation. This study reports a human familial mutation in CLPX that contributes to erythropoietic protoporphyria (EPP) by partially inactivating CLPX. Reduced CLPX activity increases ALAS post-translational stability, causing pathological accumulation of protoporphyrin IX (PPIX) in human patients. Our results thus identify an additional gene that promotes PPIX overproduction and EPP and highlight the complex gene network contributing to disorders of heme metabolism.
- 5 September 2017
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 114 (38) , E8045-E8052
Open AccessMutation in human CLPX elevates levels of δ- aminolevulinate synthase and protoporphyrin IX to promote erythropoietic protoporphyria
Significance: Although heme synthesis is ubiquitous, specific regulatory mechanisms couple heme production to cellular demand and environmental conditions. The importance of these regulatory mechanisms is highlighted by clinical variability in porphyrias caused by loss-of-function mutations in heme synthesis enzymes. Heme synthesis is also controlled by the mitochondrial AAA+ unfoldase ClpX, which participates in both heme-dependent degradation of δ-aminolevulinate synthase (ALAS) and ALAS activation. This study reports a human familial mutation in CLPX that contributes to erythropoietic protoporphyria (EPP) by partially inactivating CLPX. Reduced CLPX activity increases ALAS post-translational stability, causing pathological accumulation of protoporphyrin IX (PPIX) in human patients. Our results thus identify an additional gene that promotes PPIX overproduction and EPP and highlight the complex gene network contributing to disorders of heme metabolism.
- Open Access
- 29 May 2017
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 6
Erythropoietin signaling regulates heme biosynthesis
Heme is required for survival of all cells, and in most eukaryotes, is produced through a series of eight enzymatic reactions. Although heme production is critical for many cellular processes, how it is coupled to cellular differentiation is unknown. Here, using zebrafish, murine, and human models, we show that erythropoietin (EPO) signaling, together with the GATA1 transcriptional target,AKAP10, regulates heme biosynthesis during erythropoiesis at the outer mitochondrial membrane. This integrated pathway culminates with the direct phosphorylation of the crucial heme biosynthetic enzyme, ferrochelatase (FECH) by protein kinase A (PKA). Biochemical, pharmacological, and genetic inhibition of this signaling pathway result in a block in hemoglobin production and concomitant intracellular accumulation of protoporphyrin intermediates. Broadly, our results implicate aberrant PKA signaling in the pathogenesis of hematologic diseases. We propose a unifying model in which the erythroid transcriptional program works in concert with post-translational mechanisms to regulate heme metabolism during normal development.
- 29 May 2017
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 6
Open AccessErythropoietin signaling regulates heme biosynthesis
Heme is required for survival of all cells, and in most eukaryotes, is produced through a series of eight enzymatic reactions. Although heme production is critical for many cellular processes, how it is coupled to cellular differentiation is unknown. Here, using zebrafish, murine, and human models, we show that erythropoietin (EPO) signaling, together with the GATA1 transcriptional target,AKAP10, regulates heme biosynthesis during erythropoiesis at the outer mitochondrial membrane. This integrated pathway culminates with the direct phosphorylation of the crucial heme biosynthetic enzyme, ferrochelatase (FECH) by protein kinase A (PKA). Biochemical, pharmacological, and genetic inhibition of this signaling pathway result in a block in hemoglobin production and concomitant intracellular accumulation of protoporphyrin intermediates. Broadly, our results implicate aberrant PKA signaling in the pathogenesis of hematologic diseases. We propose a unifying model in which the erythroid transcriptional program works in concert with post-translational mechanisms to regulate heme metabolism during normal development.
- 12 May 2017
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 356 (6338) , 608-616
Restored iron transport by a small molecule promotes absorption and hemoglobinization in animals
Shipping iron around in small packages: Iron plays a crucial role in a wide variety of biological functions, which in turn rely on the proteins that transport the metal in and out of cells. Grillo et al. used a simple lipophilic small molecule that binds iron ions to restore transport in animal models with deficiencies in iron transporters. This cyclic ketol, hinokitiol, was first tested in yeast and then shown to promote gut iron absorption in rats and mice, as well as hemoglobin production in zebrafish. Science , this issue p. 608
- 12 May 2017
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 356 (6338) , 608-616
Restored iron transport by a small molecule promotes absorption and hemoglobinization in animals
Shipping iron around in small packages: Iron plays a crucial role in a wide variety of biological functions, which in turn rely on the proteins that transport the metal in and out of cells. Grillo et al. used a simple lipophilic small molecule that binds iron ions to restore transport in animal models with deficiencies in iron transporters. This cyclic ketol, hinokitiol, was first tested in yeast and then shown to promote gut iron absorption in rats and mice, as well as hemoglobin production in zebrafish. Science , this issue p. 608
- Open Access
- 1 January 2017
- Published by Oxford University Press (OUP) in Metallomics
- Vol. 9 (9) , 1193-1203
Intracellular iron and heme trafficking and metabolism in developing erythroblasts
Vertebrate red blood cells (RBCs) arise from erythroblasts in the human bone marrow through a process known as erythropoiesis.
- 1 January 2017
- Published by Oxford University Press (OUP) in Metallomics
- Vol. 9 (9) , 1193-1203
Open AccessIntracellular iron and heme trafficking and metabolism in developing erythroblasts
Vertebrate red blood cells (RBCs) arise from erythroblasts in the human bone marrow through a process known as erythropoiesis.
- 1 January 2017
- Published by Elsevier
- Vol. 138, 193-220
Studying disorders of vertebrate iron and heme metabolism using zebrafish
- 1 January 2017
- Published by Elsevier
- Vol. 138, 193-220
Studying disorders of vertebrate iron and heme metabolism using zebrafish
- 16 March 2016
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 113 (13) , 3417-3418
A role for iron deficiency in dopaminergic neurodegeneration
Disorders of iron metabolism, manifesting in iron overload or iron deficiency, are implicated in neurodegeneration (1⇓⇓⇓–5). In PNAS, Matak et al. (6) report the specific inactivation of ferroportin (Fpn, Slc40a1) and transferrin receptor 1 (TfR1) in dopaminergic (DA) neurons. The animal models generated in this study demonstrated that Fpn did not play a major role in DA neurophysiology, whereas a defect in Tfr1-dependent iron uptake caused severe iron deficiency that resulted in neurodegeneration, manifesting in behaviors that are similar to those in Parkinson’s disease (6). Iron transporters play a key role in iron homeostasis and tightly couple intracellular iron levels with cellular requirements (7). This Matak et al. (6) study examines the requirement for FPN, the only known cellular iron exporter (8⇓–10), and TFR1, a key component of the iron uptake machinery, to dissect the effects of iron overload and iron deficiency in the biology of DA neurons. Loss of Fpn function in several cell types causes iron overload (11, 12) and has been implicated in myelination defects (13). TfR1-mediated iron uptake is the main source of iron for actively proliferating cells, and is essential for iron transport in erythroid cells and neural tissue (14), epithelial enterocytes (15), skeletal muscle (16), and cardiac muscle (17), in addition to DA neurons, as described in Matak et al. (6). TfR1 deficiency in erythroid …
- 16 March 2016
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 113 (13) , 3417-3418
A role for iron deficiency in dopaminergic neurodegeneration
Disorders of iron metabolism, manifesting in iron overload or iron deficiency, are implicated in neurodegeneration (1⇓⇓⇓–5). In PNAS, Matak et al. (6) report the specific inactivation of ferroportin (Fpn, Slc40a1) and transferrin receptor 1 (TfR1) in dopaminergic (DA) neurons. The animal models generated in this study demonstrated that Fpn did not play a major role in DA neurophysiology, whereas a defect in Tfr1-dependent iron uptake caused severe iron deficiency that resulted in neurodegeneration, manifesting in behaviors that are similar to those in Parkinson’s disease (6). Iron transporters play a key role in iron homeostasis and tightly couple intracellular iron levels with cellular requirements (7). This Matak et al. (6) study examines the requirement for FPN, the only known cellular iron exporter (8⇓–10), and TFR1, a key component of the iron uptake machinery, to dissect the effects of iron overload and iron deficiency in the biology of DA neurons. Loss of Fpn function in several cell types causes iron overload (11, 12) and has been implicated in myelination defects (13). TfR1-mediated iron uptake is the main source of iron for actively proliferating cells, and is essential for iron transport in erythroid cells and neural tissue (14), epithelial enterocytes (15), skeletal muscle (16), and cardiac muscle (17), in addition to DA neurons, as described in Matak et al. (6). TfR1 deficiency in erythroid …
- Open Access
- 20 August 2015
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 100 (12) , e483-e485
Homozygous knockout of the piezo1 gene in the zebrafish is not associated with anemia
- 20 August 2015
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 100 (12) , e483-e485
Open AccessHomozygous knockout of the piezo1 gene in the zebrafish is not associated with anemia
- Open Access
- 10 August 2015
- Published by Impact Journals, LLC in Oncotarget
- Vol. 6 (25) , 20742-20743
Mitochondrial transport of protoporphyrinogen IX in erythroid cells
Comment on: Yien Y, et al. TMEM14C is required for erythroid mitochondrial heme metabolism. J. Clin. Invest. 2014; 124:4294-4304.
- 10 August 2015
- Published by Impact Journals, LLC in Oncotarget
- Vol. 6 (25) , 20742-20743
Open AccessMitochondrial transport of protoporphyrinogen IX in erythroid cells
Comment on: Yien Y, et al. TMEM14C is required for erythroid mitochondrial heme metabolism. J. Clin. Invest. 2014; 124:4294-4304.